| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |